$LRMR
Larimar Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$3.71
▼-2.37%-$0.090
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLarimar Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is LRMR down today? It is at $3.71 (-2.37%), and our scanner flagged it 48 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LRMR spikes, and full due diligence on LRMR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LRMR 48 times in the last 30 days. Create a free account to track $LRMR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on LRMR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LRMR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hamilton Thomas Edward Director | Bought (open market) | +50K 0.05% of company | added 7.5% | 715K | $167K at $3.34 | Jul 6, 26 |
Sherman Jeffrey W Director | Bought (open market) | +5K | n/a | 5K | $25K at $5.00 | Feb 27, 26 |
Thomas Frank E Director | Bought (open market) | +5K | added 100% | 7K | $25K at $5.00 | Feb 27, 26 |
Hamilton Thomas Edward Director | Bought (open market) | +100K 0.10% of company | added 18% | 665K | $500K at $5.00 | Feb 27, 26 |
Flynn James E Director | Bought (open market) | +5.00M 4.8% of company | added 16% | 35.61M | $25.0M at $5.00 | Feb 27, 26 |
Celano Michael Officer | Acquired (grant/award) | +38K 0.04% of company | added 21% | 216K | n/a | Jan 26, 26 |
Ben-Maimon Carole Officer | Acquired (grant/award) | +100K 0.10% of company | added 37% | 368K | n/a | Jan 26, 26 |
Clayton Russell Officer | Acquired (grant/award) | +26K 0.02% of company | added 56% | 71K | n/a | Jan 26, 26 |
Shankar Gopi Officer | Acquired (grant/award) | +26K 0.02% of company | added 50% | 76K | n/a | Jan 26, 26 |
Flynn James E Director | Bought (open market) | +9.38M 9.0% of company | added 44% | 30.61M | $30.0M at $3.20 | Jul 31, 25 |
Celano Michael Officer | Acquired (grant/award) | +34K 0.03% of company | added 24% | 178K | n/a | Jan 22, 25 |
Ben-Maimon Carole Officer | Acquired (grant/award) | +91K 0.09% of company | added 31% | 387K | n/a | Jan 22, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on LRMR from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LRMR today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
LRMR last traded at $3.71, down 2.37% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Larimar Therapeutics, Inc. Common Stock (LRMR) is next expected to report earnings on Wednesday, November 4, 2026, about 48 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LRMR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LRMR 48 times in the last 30 days.
LRMR (Larimar Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $408M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LRMR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LRMR discussion
Sign in to ask a question or join the discussion.